![]() |
|
|
Vol. 288, Issue 3, 960-968, March 1999
Istituto Neurologico C. Besta, Milano, Italy
| |
Abstract |
|---|
|
|
|---|
The actions of the antiepileptic drug topiramate (TPM) on Na+ currents were assessed using whole-cell patch-clamp recordings in dissociated neocortical neurons and intracellular recordings in neocortical slices. Relatively low TPM concentrations (25-30 µM) slightly inhibited the persistent fraction of Na+ current in dissociated neurons and reduced the Na+-dependent long-lasting action potential shoulders, which can be evoked in layer V pyramidal neurons after Ca++ and K+ current blockade. Conversely, the same drug concentrations were ineffective in reducing the amplitude of the fast Na+-dependent action potentials evoked in slices or the peak of transient Na+ (INaf) current evoked in isolated neurons from a physiological holding potential. Consistent INaf inhibition became, however, evident only when the neuronal membrane was kept depolarized to enhance resting Na+ channel inactivation. TPM (100 µM) was ineffective on the voltage dependence of activation but induced a leftward shift of the steady-state INaf inactivation curve. The drug-induced inhibitory effect increased with the duration of membrane depolarization, and the recovery of INaf after long membrane depolarizations was slightly delayed in comparison with that observed under control conditions. The obtained evidence suggests that the anticonvulsant action of TPM may operate by stabilizing channel inactivation, which can be induced by depolarizing events similar to those occurring in chronic epileptic conditions. Concurrently, the slight but significant inhibition of the persistent fraction of the Na+ current, obtained with the application of relatively low TPM concentrations, may contribute toward its anticonvulsant effectiveness by modulating the near-threshold depolarizing events that are sustained by this small current fraction.
| |
Introduction |
|---|
|
|
|---|
Topiramate
[TPM;
2,3:4,5-bis-O-(1-methyl-ethylidene)-36-D-fructopyranose
sulfamate] is a novel anticonvulsant drug that has recently been
licensed for clinical use in many European countries. Traditional
animal tests indicate that it primarily acts by blocking the spread of
seizure activity and that it has an anticonvulsant profile similar to
that of phenytoin and carbamazepine (Shank et al., 1994
). Accordingly,
the clinical efficacy of TPM has been particularly established in
patients with simple or complex partial seizures (Rosenfeld et al.,
1997
; Sachdeo et al., 1997
), which are also known to respond to
phenytoin and carbamazepine (Heller et al., 1995
). The basic mechanism
of action of TPM has been investigated in various experimental
preparations, and preliminary results indicate that both excitatory
(Coulter et al., 1993
, Severt et al., 1995
) and
inhibitory (Brown et al., 1993
; White et al., 1997
) chemical
neurotransmission can be modulated by the drug. Furthermore, TPM has
been found to be capable of inhibiting repetitive firing and
spontaneous bursting in cultured hippocampal neurons (Coulter et al.,
1993
), thus suggesting that it may act through a use-dependent inhibition of Na+ channels, like several other
antiepileptic agents that have been shown to inhibit sustained firing
in central neuron preparations (McLean and Macdonald, 1986
). Direct
evidence of the TPM action on transient Na+
current (INaf) was recently provided by Zona et
al. (1997)
, showing that in cultured cerebellar neurons, this drug
induces a voltage-dependent inhibition that becomes evident at
depolarized membrane potentials.
A significant effect on Na+ currents has been
demonstrated for several other "traditional" and "new"
antiepileptic drugs, such as phenytoin, carbamazepine, valproate
(Matsuki et al., 1984
; Willow et al., 1985
; Kuo and Bean, 1994a
;
Ragsdale et al., 1996
), and lamotrigine (Cheung et al., 1992
; Xie et
al., 1995
; Kuo and Lu, 1997
). Together, these findings suggest that
Na+ current inhibition may play a primary role in
the mechanism of action of antiepileptic drugs, especially those that
are effective against partial seizures. Experimental evidence suggests
that antiepileptic drugs, such as phenytoin, carbamazepine (Matsuki et
al., 1984
; Willow et al., 1985
; Kuo and Bean, 1994a
; Ragsdale et al.,
1996
), and lamotrigine (Xie et al., 1995
) exert a voltage-dependent effect on voltage-gated Na+ channels by
preferentially acting on inactivated channels. This suggests that their
inhibitory action is turned on by long-lasting depolarizing potentials,
similar to those characterizing epileptic ictal phenomena, leaving the
generation of physiological Na+-dependent action
potentials (APs) unaffected.
An additional antiepileptic mechanism affecting
Na+ currents was recently proposed by Chao and
Alzheimer (1995)
for phenytoin, which was found to selectively reduce
the persistent fraction of Na+ currents
(INaP) at concentrations lower than those capable
of reducing the peak of the fast Na+ current.
Because this small fraction of the Na+ current is
known to play an important role in regulating the firing
characteristics of neocortical pyramidal neurons (Stafstrom et al.,
1985
; Franceschetti et al., 1995
; Crill, 1996
; Fleidervish and Gutnick,
1996
; Guatteo et al., 1996
, Mantegazza et al., 1998
) and has been found
to contribute to the generation of epileptiform activity (Segal and
Douglas, 1997
), it can be considered to be a further significant target
when studying the Na+ channel-operated effects of
new antiepileptic drugs. We here report the results of voltage-clamp
experiments performed on acutely dissociated neocortical neurons, with
the aim of investigating the effects of TPM on both the transient and
persistent components of Na+ current. Control
intracellular recordings to verify the drug effect on neocortical
neurons were made using slice experiments
| |
Materials and Methods |
|---|
|
|
|---|
Slice and Cell Preparation. Ten- to 20-day-old Wistar rats (Charles River, Italy) were anesthetized with chloral hydrate (Fluka AG, Buchs, Switzerland) and decapitated. Then brains were removed and placed in ice-cold artificial cerebrospinal fluid (ACSF) of the following composition: 120 mM NaCl, 24 mM NaHCO3, 1 mM CaCl2, 1 mM NaHPO4, 4 mM MgCl2, 2.5 mM KCl, and 20 mM glucose, bubbled with 95% O2 and 5% CO2. Coronal slices with a thickness of 300 to 350 µm were cut from the dorsal frontoparietal cortex using a vibratome. The slices used for the current-clamp experiments were transferred to an interface chamber, perfused with ACSF, and allowed to equilibrate for 1 to 1.5 h before the electrophysiological recordings were started. The dissociated neurons for the patch-clamp experiments were prepared from slices kept for 10 to 15 min in modified ACSF [in which NaHCO3 was partially substituted with 10 mM HEPES-NaOH bubbled with 95% O2 and 5% CO2 at 35°C, pH 7.4] with the addition of 1 mM kynurenic acid and 1 mg/ml Protease Type XIV to digest the extracellular matrix; after enzyme treatment, the slices were washed and stored in an enzyme-free solution. At the recording time, the neurons were dissociated using fire-polished Pasteur pipettes, plated in a Petri dish (Costar Corp., Cambridge, MA), left 3 to 5 min to allow attachment, and then bath perfused with modified ACSF (see below). Only large neurons with a pyramidal shape were selected for patch-clamp recordings.
Electrophysiological Recordings.
The intracellular
recordings in slices were performed on layer V pyramidal neurons using
an IR-283 (Neuro Data Inst. Corp., New York) amplifier. Sharp
electrodes were prepared using borosilicate glass capillaries (Clark
Electromedical Inst.) and filled with 3 M K+ acetate
(resistance 80-90 M
). Only healthy neurons with a stable spontaneous resting membrane potential
(Vrest) that was more negative than
60 mV,
a stable firing level and overshooting APs were selected for the
analysis. Voltage and current signals were displayed on a Tektronix
storage oscilloscope and stored on a magnetic tape. To isolate the
Na+ currents, after neuron impalement the slices were bath
perfused by a solution of 60 mM NaCl, 60 mM tetraethylammonium Cl, 0.2 mM CaCl2, 7 mM MgCl2, 2 mM CdCl2,
24 mM NaHCO3, and 10 mM glucose (pH 7.4), bubbled with 95%
O2 and 5% CO2.
, linear leakage and capacitative currents were
minimized by means of the amplifier circuitry; junction potential
errors were not corrected, and the remaining leakage currents were
eliminated using the P/4 subtraction protocol; the membrane currents
were filtered at 3 kHz (voltage steps) or 1 kHz (voltage ramps). The
data were analyzed using pClamp and Origin 4.0 (Microcal Inc.) software
on a Pentium 166 PC.
To record the Na+ currents, borosilicate glass
electrodes were filled with 75 mM CsF, 55 mM CsCl, 1 mM
MgCl2, 10 mM ethylene glycol bis(
-aminoethyl
ether)-N,N,N',N'-tetraacetic
acid-CsOH, 10 mM HEPES-CsOH, 2 Na2ATP, 10 mM
phosphocreatine-di-Tris, and 20 units/ml creatine phosphokinase, pH 7.2 (2-3 M
), and the neurons were bath perfused with a modified ACSF
containing 120 mM NaCl, 1.3 mM CaCl2, 2 mM
MgCl2, 0.4 mM CdCl2, 0.3 mM
NiCl2, 20 mM tetraethylammonium, 10 mM
HEPES-NaOH, and 10 mM glucose, pH 7.3, bubbled with pure oxygen. In the
experiments aimed at recording fast Na+ currents,
NaCl was lowered to 10 mM and partially substituted with choline-Cl
(110 mM) to avoid voltage-clamp errors. The statistical results are
given as mean ± S.E.M. values; statistical significance was
evaluated using the two-tailed Student's t test for paired data.
TPM (The R.A.W. Johnson Pharmaceutical Research Institute, Rarity, NJ)
was dissolved in water at a concentration of 20 mM and stored at
20°C; at the recording time, the drug was dissolved in the
perfusing solutions. In the dissociated neurons, TPM was bath applied
at concentrations ranging from 10 to 200 µM; in the slices, TPM was
added to ACSF at concentrations of 30 and 100 µM.
| |
Results |
|---|
|
|
|---|
Using the whole-cell configuration of the patch-clamp technique, voltage-clamp recordings were obtained from 40 pyramidal neurons acutely dissociated from rat sensorimotor cortex slices. The intracellular recordings in current-clamp configuration were made in 9 pyramidal neurons of layer V in slices of sensorimotor cortex.
In preliminary experiments, rather high TPM concentrations (100-400
µM) were tested on the Na+-dependent APs
generated by isolated neocortical neurons, which were recorded in
current-clamp configuration and stimulated by brief (1.5-ms)
depolarizing current pulses. The main drug effect was a reduction in
the long-lasting AP shoulder (Fig. 1),
which becomes visible after K+ and
Ca++ current blockade and is sustained by
INaP (Stafstrom et al., 1985
); with 200 µM TPM
concentration, the duration of AP shoulder was reduced from 32.1 ± 8.1 to 19.2 ± 6.3 ms (n = 3). Voltage-clamp experiments on dissociated neurons then were carried out to further characterize the effects of TPM on both the transient and persistent components of Na+ currents and to establish the
effective drug concentration.
|
TPM Effect on Persistent Fraction of Na+ Current.
A first series of experiments was designed to evaluate the effect of
TPM on the persistent fraction of Na+ current
(INaP), which was evoked in dissociated pyramidal neurons using slowly rising ramps as voltage stimuli. Depolarizing ramp potentials (from
70 to +10 mV at a rate of 80 mV/s), which were slow
enough to avoid transient Na+ channel opening, were
consistently capable of evoking a small inward TTX-sensitive
Na+ current, which is considered to be accounted for by
INaP (Alzheimer et al., 1993
; Brown et al., 1994
). The
INaP in cortical neurons typically begins to activate
between
60 and
50 mV and has a broad peak at about
40 mV (Fig.
2A), as previously found by French et al.
(1990)
, Alzheimer et al. (1993)
, and Brown et al. (1994)
. A
contaminating outward current (Fig. 2A), which was insensitive to the
K+ blockers and remained after the addition of 1 µM TTX,
was frequently found to activate at more positive potentials (more than
25 mV) and was assumed to correspond to the cationic current
described by Alzheimer (1994)
in neocortical neurons.
|
Effect of TPM on Transient Na+ Current (INaf). The experiments were performed after partially substituting NaCl with choline-Cl (see Materials and Methods) to reduce voltage-clamp errors due to the large INaf observed in pyramidal neocortical neurons. Under this conditions, the maximum peak amplitude of INaf never exceeded 2.5 nA (range, 0.4-2.5 nA).
INaf was evoked by means of families of 200-ms depolarizing step potentials up to +55 mV, delivered from a holding potential of
70 mV, close to the spontaneous
Vrest found in neocortical pyramidal
neurons recorded in slices (
68.4 ± 4.3 mV) (Franceschetti et
al., 1995
90 mV) or depolarized (
60 mV) holding potential to change the fraction of inactivated Na+ channels and therefore to evaluate the
influence of the resting Na+ channel inactivation
on effect of TPM.
The lower TPM concentration (30 µM) used in these experiments was
unable to inhibit INaf when the test pulses were
delivered from a holding potential of
70 mV (Fig.
3A) but did so slightly and consistently
when the test pulses were delivered from a depolarizing holding of
60
mV (Fig. 3B). The normalized current/voltage relationship evaluated
using step depolarizations delivered from
60 mV holding is shown in
Fig. 3C. The maximum INaf peak amplitude
typically evoked in response to depolarizing test pulses to
15 mV was
reduced by 20.0 ± 0.1% in the presence of TPM (four neurons).
|
70-mV holding potential (23 ± 4%; four neurons) and considerably
increased (reaching 42 ± 6%; five neurons) when the membrane
potential was held at
60 mV; however, the inhibitory effect was
prevented when the membrane was hyperpolarized to
90 mV
(n = 3) to deinactivate most of the
Na+ channels before evoking
INaf .
|
Effect of TPM on Activation and Inactivation of Na+
Channels.
The voltage dependence of Na+ channel
activation appeared to be unaffected by both 30 µM (not shown) and
100 µM TPM. The fast activation curves of the Na+
channels evaluated under control conditions and in the presence of 100 µM TPM in four neurons held at
60 mV are shown in Fig. 4D. The
conductance of the Na+ channels
(GNa) was calculated by the equation
GNa = INaf/(V
VNa), where INaf is the maximal
inward current, V is the command potential, and
VNa is the theoretical reversal potential
(calculated by means of the Nernst equation to be +33.8 mV with 15 mM
Na+ in the external solution). The normalized conductance
(G/Gmax) was plotted against
the command potential following the Boltzmann relation:
G/Gmax = 1/(1 + exp[(V1/2
V)/k]), where
G/Gmax is the relative
conductance, V1/2 is the voltage at which
half-maximal activation is reached, and k is the slope
factor. Under control conditions, the half-maximal activation potential
(V1/2) was
18.2 mV and k
was 9.2 mV/e-fold; in the presence of 100 µM TPM,
V1/2 was
20.0 mV and k was
8.9 mV/e-fold.
105 to
45 mV before
depolarizing test pulses to
15 mV to evoke
INaf. Under control conditions and in the
presence of 100 µM TPM, the steady-state inactivation curve could be
fitted using the Boltzmann equation: I/Imax =1/(1 + exp[(V
V1/2)/k]). The addition of
the drug caused a hyperpolarizing shift of the curve, without inducing
any significant changes in its slope factor. The mean values of
V1/2 evaluated on four neurons (Fig.
4E) were
62.1 ± 0.4 mV under control conditions and
69.1 ± 0.2 mV in the presence of 100 µM TPM (p < .05);
the value of k was 5.7 mV/e-fold change under control
conditions and 5.9 mV/e-fold in the presence of TPM.
To investigate the time dependence of the effect of TPM on
INaf, we applied a stimulus protocol that
included progressively longer (from 240-800 ms in 55-ms steps)
depolarizing prepulses to
45 mV delivered before the depolarizing
test pulses to
15 mV. A short (40-ms) hyperpolarizing current pulse
to
90 mV was delivered at the end of the depolarizing prestimulus
with the aim of removing fast inactivation. As shown in Fig.
5A, the INaf peak
values elicited by the test pulses under control conditions progressively declined in line with the increase in the duration of the
depolarizing prepulse; this can be attributed to incoming slow
inactivation. In the presence of TPM (Fig. 5B), the decline in
INaf peak amplitudes was greatly enhanced. In
Fig. 5C, the mean values obtained in three neurons are plotted against
the length of the conditioning pulses; the measured
INaf peak amplitudes were normalized with respect
to the maximal current, obtained after the first delivered prepulse
(240 ms). Under control conditions and in the presence of the drug, the
values of the INaf peak amplitude could be fitted
using a single exponential function. The time constant of the
exponential fitting was found to be slightly slower in the presence of
the drug (344.6 ± 39.4 versus 258.2 ± 49.2 ms), thus
indicating an increase in the drug action in parallel with the
development of channel inactivation.
|
10 mV,
followed by a deinactivating hyperpolarizing prepulse to
90 mV of
progressively increasing length. Both under control conditions and in
presence of the drug, the time course of recovery could be fitted using
a single exponential function (Fig. 5D). The control
value of
70.6 ± 11.2 ms increased to 182.4 ± 46.2 ms after the
addition of the drug.
Effect of TPM on Na+-Dependent Potentials Recorded in
Slices.
The intrinsically bursting neurons recorded in slice
experiments were perfused with 30 and 100 µM TPM dissolved in bath
solution. When most of the hyperpolarizing K+ currents were
blocked by means of a high extracellular TEA concentration (40 mM) and
the Ca++-dependent K+ currents were blocked by
substituting Ca++ ions with Co++ or
Mn++, the intrinsically bursting pyramidal neurons
discharged with a fast AP followed by a very long depolarizing shoulder
arising from AP repolarizing phase at about
20 mV and lasting 800 to 2000 ms. The neurons were left at spontaneous
Vrest (
65.5 ± 0.7 mV) and
small changes in membrane potential, occasionally occurring during the
recording time, were adjusted to the control
Vrest by injecting weak DC currents. TPM 30 µM did not modify the amplitude and shape of the fast
Na+-dependent AP (Fig. 6A)
but consistently shortened the depolarizing shoulders (Fig. 6B); the
length of the depolarizing shoulders was 1347 ± 650 ms under
control conditions (mean of four sweeps measured on six neurons),
782.5 ± 403.0 ms during the addition of TPM
(p < .02), and recovered during wash-out
(1083.9 ± 560 ms, p = .68). Conversely, TPM
100 µM slightly decreased the peak amplitude of the AP (Fig. 6A) and
induced a progressive reduction to the point of almost complete
suppression of the long-lasting depolarizing plateau after AP
activation (Fig. 6B).
|
| |
Discussion |
|---|
|
|
|---|
The data from this study demonstrate that relatively low TPM
concentrations are capable of significantly inhibiting both the fast
and persistent components of Na+ currents in
neocortical neurons: 25 to 30 µM TPM concentrations were found to
inhibit INaP by about 20% in dissociated
neocortical neurons and to reduce the INaf peak
amplitude provided that it was evoked from a slightly depolarized
holding potential. The therapeutic values of TPM blood levels have been
little investigated in clinical trials; however, the little published
data indicate that the single (Johannessen, 1997
) or chronic (Perucca,
1997
) administration of an effective daily dose of 400 to 1200 mg/day give rise to plasma levels ranging from 4 to 10 µg/ml, which are very
close to the lower TPM concentrations used in the present study.
The evidence that relatively low TPM concentrations principally inhibit
the persistent fraction of Na+ current when the
neurons were stimulated starting from their spontaneous
Vrest, currently close to
70 mV
(Tseng and Prince, 1993
; Franceschetti et al., 1995
, 1998
), is
supported by the results obtained in the voltage-clamp experiments
performed on dissociated neurons and confirmed by the current-clamp
experiments on neocortical slices. TPM 30 µM did not affect
"fast" APs in the layer V pyramidal neurons but consistently
shortened the long-lasting AP shoulders, which are revealed by
Ca++ and K+ blockade and
have been attributed to INaP. Different ionic
mechanisms contribute to afterdepolarization in neocortical neurons
(Friedman et al., 1992
; Reuveni et al., 1993
) and, among them, a
cationic current, sensitive to phenytoin inhibition, recently described by Kang et al. (1998)
. However, the large plateaux potentials that were
found to be blocked by the TPM have been previously demonstrated to be
sustained by a persistent TTX-sensitive Na+
current (Stafstrom et al., 1985
) that is prominent in layer V of IB
neurons (Franceschetti et al., 1995
).
It has been shown that INaP and
INaf in neocortical neurons are generated by
uniform channel population that can switch to different gating modes,
so INaP can be sustained by the small fraction of
Na+ channels that fail to inactivate despite
membrane depolarization, thus giving rise to sustained burst of channel
openings (Alzheimer et al., 1993
; Brown et al., 1994
). This opening
mode can be activated by a slow rising depolarization (such as that
induced by a slow ramp potential) and has been shown to underlie the
depolarizing plateaux potentials that spontaneously occur in an in
vitro model of seizure-like activity obtained in cultured hippocampal
neurons (Segal, 1994
; Segal and Douglas, 1997
). Stabilization of
Na+ channels in their inactivated state could
prevent their late opening and thus account for the TPM-induced
inhibition of INaP that we found in both
dissociated neurons and slices. Moreover, our results with TPM agree
with those previously obtained with phenytoin, which, at concentrations
significantly lower than those needed to inhibit the
INaf, has been found to reduce
INaP amplitude in dissociated neocortical neurons
(Chao and Alzheimer, 1995
) and to prevent the late channel opening in
the above-mentioned model of ictal epileptiform activity obtained in
hippocampal neurons (Segal and Douglas, 1997
).
Binding to the inactivated state of Na+
channels, capable of preventing any transition that would allow channel
reopening, could account not only for the effect of TPM on
INaP but also for most of its effects on
INaf, which can be revealed by means of different
inactivating procedures. This assumption is further supported by the
finding that membrane hyperpolarization at
90 mV, which is suitable
for removing most of the channel inactivation, was sufficient to
prevent drug activity even when it was added at higher concentrations
(100 µM). Experiments aimed at further clarifying the dynamics and
the mechanisms through which TPM can influence
Na+ channels were performed using a 100 µM drug
concentration, which in our study approximated the concentration that
inhibits the persistent fraction of Na+ current
by about 50% and also was sufficient to slightly inhibit the
INaf peak in neocortical neurons held at
70 mV.
In the presence of the drug, the steady-state
INaf inactivation curve was found to be
significantly shifted to more hyperpolarized potentials without any
significant slope changes. This suggests that TPM binding is capable of
preventing channel transition from an inactivated to a deinactivated
state during the depolarizing prepulse and that less positive
subthreshold depolarizing events are needed to decrease
Na+-mediated membrane excitability. A leftward
shift in steady-state inactivation has been previously reported to be
induced by several anticonvulsants and by other drugs acting on
Na+ channels (i.e., antiarrhythmic agents and
local anesthetics) (Willow et al., 1985
; Kuo and Bean, 1994a
; Ragsdale
et al., 1996
); moreover, it has been found to occur in cultured
granular neurons exposed to TPM (Zona et al., 1997
), thus further
indicating that drugs capable of controlling intrinsic membrane
excitability can act by favoring steady Na+
channel inactivation.
The effect of TPM on INaf was not only
voltage but also time dependent: drug-induced inhibition of
INaf regularly increased when the neuronal
membrane was kept depolarized by progressively longer conditioning
prepulses at
40 mV. Furthermore, the recovery from the inactivation
appeared to be slower in the presence of the drug than under control
conditions. Both of these effects may be attributable to preferential
drug binding on the slowly inactivated channel state, which is known to
occur during long-lasting depolarizations (Ruben et al., 1992
), or
conversely, they could be due to slowly occurring binding and unbinding
to the fast inactivated or closed but "activated" channel states,
as proposed by Kuo and Bean (1994b)
. According to the hypothesis
formulated by these authors to elucidate the action of phenytoin (which
is the more extensively studied of the anticonvulsants acting on
Na+ channels), drug binding may be slow but tight
to the "activated" channels (i.e., channels with at least one
gating charge in the "on" position), thus supporting the
time-dependent increase in the inhibitory effect and the delayed
recovery in response to a deinactivating hyperpolarization. Different
anticonvulsant molecules might have different affinities for the
activated Na+ channels (or different speeds of
binding and unbinding), which can establish the time course of drug
action and presumably imply differences in therapeutic effects (Kuo and
Lu, 1997
).
TPM-induced INaf inhibition regularly increased
with the length of the depolarizing prepulses, as has also been
reported for phenytoin (Kuo and Bean, 1994a
), but the recovery due to
deinactivating hyperpolarizing pulses was found to be more rapid than
that associated with phenytoin and apparently comparable to that of
carbamazepine and lamotrigine (Xie et al., 1995
; Kuo et al., 1997
).
This suggests that the drug may regularly increase its effectiveness
during long-lasting depolarizing events by adding to the normally
occurring slow Na+ channel inactivation, whereas
its effect may be more quickly removed by incoming hyperpolarizations,
which can be sustained by either synaptic inhibition or hyperpolarizing currents.
Na+ Current Inhibition as an Antiepileptic Effect of
TPM.
TPM has been reported to possess multiple mechanisms of
action and to be capable of modifying both
-aminobutyric
acidA- and kainate-evoked ion flow at very low
concentrations (Severt et al., 1995
; White et al., 1997
), and the drug
probably can act on different seizure types throughout its different
effects (see Perucca, 1997
, for review). The present data show that
like some other anticonvulsants known to be especially effective
against focal seizures, TPM can inhibit Na+ currents, and
that this action may occur at potentially therapeutic concentrations.
Moreover, there is evidence to indicate that such relatively low drug
concentrations should not significantly affect the physiological
generation APs in well polarized neurons, and the drug action would
come into play as much as sustained depolarizing events or
high-frequency AP discharges are capable of reducing the fraction of
the "resting" Na+ channels. Possible contribution
toward controlling membrane hyperexcitability comes from the ability of
TPM to inhibit INaP because the channel opening mode
sustaining this current fraction may play a part in the generation of
ictal events (Segal, 1994
). Moreover, because INaP starts
activating at more negative potentials than INaf (French et
al., 1990
; Alzheimer et al., 1993
; Segal and Douglas, 1997
), its
inhibition may prevent membrane depolarizations before a neuron starts
to fire. Furthermore, a TPM-induced limitation of the intrinsic INaP dependent bursting behavior may contribute
significantly to reduce epileptic synchronization (Chagnac-Amitai and
Connors, 1989
).
| |
Acknowledgments |
|---|
The assistance of R.A.W. Johnson Pharmaceutical Research Institute in supplying TPM is gratefully acknowledged.
| |
Footnotes |
|---|
Accepted for publication September 29, 1998.
Received for publication May 29, 1998.
Send reprint requests to: Dr. Silvana Franceschetti, Istituto Neurologico C. Besta, Department of Neurophysiology, via Celoria 11, 20133 Milano, Italy. E-mail: franceschetti{at}istituto-besta.it
| |
Abbreviations |
|---|
INaf, transient sodium current; INaP, persistent sodium current; TPM, topiramate; ACSF, artificial cerebrospinal fluid; AP, action potential; TTX, tetrodotoxin.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Remy and H. Beck Molecular and cellular mechanisms of pharmacoresistance in epilepsy Brain, January 1, 2006; 129(1): 18 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Chung and M. D Reed Intentional Topiramate Ingestion in an Adolescent Female Ann. Pharmacother., September 1, 2004; 38(9): 1439 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Z. Wetmore and S. N. Baker Post-spike distance-to-threshold trajectories of neurones in monkey motor cortex J. Physiol., March 15, 2004; 555(3): 831 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Gryder and M. A. Rogawski Selective Antagonism of GluR5 Kainate-Receptor-Mediated Synaptic Currents by Topiramate in Rat Basolateral Amygdala Neurons J. Neurosci., August 6, 2003; 23(18): 7069 - 7074. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||